Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
COMPOSITIONS COMPRISING CYCLIC PURINE DINUCLEOTIDES HAVING DEFINED STEREOCHEMISTRIES AND METHODS FOR THEIR PREPARATION AND USE
No-Receipt date
2019-01489 - 11/04/2019
No-Filing date
20190401169 - 11/04/2019
No-Granting date
3099559 - 08/05/2019
No-EPO application date
13863379.7 - 13/12/2013
No-EPO granting date
2931738 - 06/02/2019
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
5/2019 - 20/06/2019
Expiration date
14/12/2033
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US201261737006 P13/12/2012/US
US201361790514 P15/03/2013/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 37/02
A61P 37/04
C07H 21/00
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1005133
ADURO BIOTECH, INC.
740 HEINZ AVENUE
BERKELEY, CA 94710
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
2523443
DUBENSKY, JR.,THOMAS, W.
2523444
KANNE, DAVID, B.
2523445
LEONG, MEREDITH, LAI LING
2523446
LEMMENS, EDWARD, EMILE
2523447
GLICKMAN, LAURA, HIX
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
7/6/2022 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 06/2022 Αρ. Πρωτ. ΓΔ 1726 / 06.07.2022
Payments history
8 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).